ANDA 213612

SINOTHERAPEUTICS INC

FDA Drug Application

Application #213612

Application Sponsors

ANDA 213612

SINOTHERAPEUTICS INC

Marketing Status

• Prescription: 001
• Prescription: 002
• Prescription: 003

Application Products

001	TABLET, EXTENDED RELEASE;ORAL	EQ 12.5MG BASE	0	PAROXETINE HYDROCHLORIDE	PAROXETINE HYDROCHLORIDE
002	TABLET, EXTENDED RELEASE;ORAL	EQ 25MG BASE	0	PAROXETINE HYDROCHLORIDE	PAROXETINE HYDROCHLORIDE
003	TABLET, EXTENDED RELEASE;ORAL	EQ 37.5MG BASE	0	PAROXETINE HYDROCHLORIDE	PAROXETINE HYDROCHLORIDE

FDA Submissions

UNKNOWN;

ORIG

1

AP

2021-08-11

STANDARD

Submissions Property Types

ORIG

1

Null

7

TE Codes

001	Prescription	AB
002	Prescription	AB
003	Prescription	AB

CDER Filings

SINOTHERAPEUTICS INC

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213612
            [companyName] => SINOTHERAPEUTICS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"PAROXETINE HYDROCHLORIDE","activeIngredients":"PAROXETINE HYDROCHLORIDE","strength":"EQ 12.5MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"PAROXETINE HYDROCHLORIDE","activeIngredients":"PAROXETINE HYDROCHLORIDE","strength":"EQ 25MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/11\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-08-11
        )

)